Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
- الموضوع:Adult; Aged; 80 and over; Antimetabolites; Antineoplastic/administration & dosage; Antineoplastic Agents/administration & dosage; Antineoplastic Agents; Phytogenic/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma; Non-Small-Cell Lung/drug therapy; Cisplatin/administration & dosage; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease-Free Survival; Female; Humans; Karnofsky Performance Status; Lung Neoplasms/drug therapy; Male; Maximum Tolerated Dose; Middle Aged; Taxoids/administration & dosage; Cisplatin; Docetaxel; Elderly patients; Gemcitabine; Non-small cell lung cancer
- نوع التسجيلة:article in journal/newspaper
- اللغة:English
No Comments.